SavedAdd your journal

Journals / Endokrinolojide Diyalog Dergisi / 2013 / Cilt: 10 - Sayı: 2

Relationship between metabolic syndrome and erectile dysfunction

Metabolik sendrom ve erektil disfonksiyon ilişkisi

Yılmaz ASLAN
Ali ATAN
Tanju KETEN
Pages
86–92
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study the current situation between the pathophysiology of MS and ED is presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Erectile dysfunction (ED) is defined as the persistent inability to achieve or maintain penile erection sufficient for satisfactory sexual performance.
📊
Key Findings & Data:Endothelial dysfunction is an earlier state of vascular damage that may cause the loss of vasodilatation depending on normal endothelium and significant atherosclerotic changes in systemic circulation.
💡
Conclusion & Impact:In this study the current situation between the pathophysiology of MS and ED is presented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Erectile dysfunction (ED) is defined as the persistent inability to achieve or maintain penile erection sufficient for satisfactory sexual performance. In epidemiological studies smoking, hypertension, diabetes mellitus, hypercholesterolemia, obesity and sedentary lifestyle are mentioned as important risk factors of ED. Endothelial dsyfunction plays an important role in the pathophysiology of developing ED. Endothelial dysfunction is an earlier state of vascular damage that may cause the loss of vasodilatation depending on normal endothelium and significant atherosclerotic changes in systemic circulation. MS has become increasingly important in the last century and it is one of the important reasons of cardiovascular morbidity and mortality. MS includes the common risk factors of developing endothelial dysfunction that cause cardiovascular disease and ED. In this study the current situation between the pathophysiology of MS and ED is presented.

Özet

Erektil disfonksiyon (ED), tatmin edici bir cinsel performans için yeterli ereksiyonu sağlama ve sürdürmede yetersizlik olarak tanımlanır. Epidemiyolojik çalışmalar sigara kullanımı, hipertansiyon, diyabet, hiperkolesterolemi, obezite, sedanter yaşam tarzının ED için önemli risk faktörleri olduğunu belirtmektedir. ED patofizyolojisinde endotel disfonksiyon önemli rol oynamaktadır. Endoteliyal disfonksiyon, normal endoteliyal bağımlı vazodilatasyonun kaybına neden olan, sistemik dolaşımda daha ciddi aterosklerotik değişikliklere yol açabilecek vasküler hasarlanmaların erken bir evresidir. MS son yüzyılda gittikçe önem kazanan ve gelişmiş ülkelerde kardiyovasküler mortalite ve morbiditenin önemli nedenlerden biridir. MS, KVH ve EDye yol açan endoteliyal disfonksiyonun gelişimi için ortak risk faktörlerini içermektedir. Bu derlemede MS ve ED arasındaki fizyopatolojisinin güncel durumu sunulmaktadır.

🔖

Cite This Article

ASLAN, Y., ATAN, A., KETEN, T. (2022). Relationship between metabolic syndrome and erectile dysfunction. Endokrinolojide Diyalog Dergisi, Cilt: 10 - Sayı: 2, 86–92. https://ajindex.com/articles/500696

References (15)

  1. Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive study. J Clin En- docrinol Metab 2009;94:1853–1878
  2. Gorbachinsky I, Akpinar H, Assimos DG. Metabolic syndrome and urologic diseases. Rev Urol 2010;12(4):e157-80
  3. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752
  4. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. A prospective study of risk factors for erectile dysfunction. J Urol 2006;176(1):217-221
  5. Traish AM, Guay A, Feeley R, Saad F. The dark side of testos- terone deficiency: I. metabolic syndrome and erectile dysfunc- tion. J Androl 2009;30(1):10-22
  6. Brotman DJ, Girod JP. The metabolic syndrome: a tug-of-war with no winner. Cleve Clin J Med 2002;69(12):990-4
  7. Müller A, Mulhall JP. Cardiovascular disease, metabolic syndrome and erectile dysfunction. Curr Opin Urol 2006;16(6):435-43
  8. Theuma P, Fonseca VA. Novel cardiovascular risk factors and macrovascular and microvascular complications of diabetes. Curr Drug Targets 2003;4(6):477-86
  9. Esposito K, Giugliano F, Martedì E, et al. High proportions of erectile dysfunction in men with the metabolic syndrome. Dia- betes Care 2005;28(5):1201-3
  10. Hammarsten J, Peeker R. Urological aspects of the metabolic syndrome. Nat Rev Urol 2011;8(9):483-94
  11. Aslan Y, Sezgin T, Tuncel A, Tekdogan UY, Guler S, Atan A. Is type 2 diabetes mellitus a cause of severe erectile dysfunction in patients with metabolic syndrome? Urology 2009;74(3):561- 4
  12. Heidler S, Temml C, Broessner C, et al. Is the metabolic syndrome an independent risk factor for erectile dysfunction? J Urol 2007;177:651-654
  13. Bal K, Oder M, Sahin AS, et al. Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: metabolic backgrounds of erectile dysfunction. Urology 2007;69:356-360
  14. Demir T, Demir O, Kefi A, Comlekci A, Yesil S, Esen A. Prevalence of erectile dysfunction in patients with metabolic syndrome. Int J Urol 2006;13(4):385-8
  15. Paick JS, Yang JH, Kim SW, Ku JH. Are age, anthropometry and components of metabolic syndrome-risk factors interrela- ted with lower urinary tract symptoms in patients with erectile dysfunction? A prospective study. Asian J Androl 2007;9(2):213-